Skip to main content

Table 4 Number of days of disposable income to afford anti-malarials

From: Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya

 

Outlet type

 

Private

Not-for-profit

Anti-malarials

  

AL

0.50

0.40

Other forms of ACT

3.20

1.34

Quinine

0.54

0.40

  1. AL, artemether-lumefantrine; ACT, artemisinin-based combination therapy. Affordability was expressed as median price (numerator) against lowest daily disposable income level (at KES 150, USD 1.875 = denominator).
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us